Works by Petrausch, Ulf


Results: 24
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastim.

    Published in:
    Annals of Hematology, 2011, v. 90, n. 1, p. 89, doi. 10.1007/s00277-010-1036-8
    By:
    • Samaras, Panagiotis;
    • Blickenstorfer, Marcel;
    • Siciliano, Raffaele Daniele;
    • Haile, Sarah R.;
    • Buset, Elefteri M.;
    • Petrausch, Ulf;
    • Mischo, Axel;
    • Honegger, Hanspeter;
    • Schanz, Urs;
    • Stussi, Georg;
    • Stahel, Rolf A.;
    • Knuth, Alexander;
    • Stenner-Liewen, Frank;
    • Renner, Christoph
    Publication type:
    Article
    10
    11
    12
    13

    Diffuses, grosszelliges B-Zell-Lymphom (DLBCL).

    Published in:
    Praxis (16618157), 2015, v. 104, n. 9, p. 441, doi. 10.1024/1661-8157/a001998
    By:
    • Samaras, Panagiotis;
    • Fuchs, Ivo;
    • Petrausch, Ulf;
    • Pangalu, Athina;
    • Schäfer, Niklaus
    Publication type:
    Article
    14
    15
    16
    17
    18

    Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID‐19 vaccine in haemato‐oncological patients with no antibody response.

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 3, p. 577, doi. 10.1111/bjh.17982
    By:
    • Reimann, Patrick;
    • Ulmer, Hanno;
    • Mutschlechner, Beatrix;
    • Benda, Magdalena;
    • Severgnini, Luciano;
    • Volgger, Andreas;
    • Lang, Theresia;
    • Atzl, Michele;
    • Huynh, Minh;
    • Gasser, Klaus;
    • Grabher, Claudia;
    • Mink, Sylvia;
    • Fraunberger, Peter;
    • Petrausch, Ulf;
    • Hartmann, Bernd;
    • Winder, Thomas
    Publication type:
    Article
    19

    Serological SARS‐CoV‐2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID‐19 vaccine in haematological and oncological patients.

    Published in:
    British Journal of Haematology, 2021, v. 195, n. 4, p. 523, doi. 10.1111/bjh.17743
    By:
    • Benda, Magdalena;
    • Mutschlechner, Beatrix;
    • Ulmer, Hanno;
    • Grabher, Claudia;
    • Severgnini, Luciano;
    • Volgger, Andreas;
    • Reimann, Patrick;
    • Lang, Theresia;
    • Atzl, Michele;
    • Huynh, Minh;
    • Gasser, Klaus;
    • Petrausch, Ulf;
    • Fraunberger, Peter;
    • Hartmann, Bernd;
    • Winder, Thomas
    Publication type:
    Article
    20
    21
    22
    23

    Efficacious and save use of biosimilar filgrastim for hematopoietic progenitor cell chemo-mobilization with vinorelbine in multiple myeloma patients.

    Published in:
    Journal of Clinical Apheresis, 2017, v. 32, n. 1, p. 21, doi. 10.1002/jca.21459
    By:
    • Maul, Julia ‐ Tatjana;
    • Stenner ‐ Liewen, Frank;
    • Seifert, Burkhardt;
    • Pfrommer, Sarah;
    • Petrausch, Ulf;
    • Kiessling, Michael K.;
    • Schanz, Urs;
    • Nair, Gayathri;
    • Mischo, Axel;
    • Taverna, Christian;
    • Schmidt, Adrian;
    • Bargetzi, Mario;
    • Stupp, Roger;
    • Renner, Christoph;
    • Samaras, Panagiotis
    Publication type:
    Article
    24

    Safety and quality of cystectomy and pelvic lymph node dissection after neoadjuvant durvalumab and cisplatin/gemcitabine.

    Published in:
    BJU International, 2024, v. 134, n. 3, p. 388, doi. 10.1111/bju.16318
    By:
    • Afferi, Luca;
    • Spahn, Martin;
    • Hayoz, Stefanie;
    • Strebel, Räto T.;
    • Rothschild, Sacha I.;
    • Seifert, Helge;
    • Özdemir, Berna C.;
    • Kiss, Bernhard;
    • Maletzki, Philipp;
    • Engeler, Daniel;
    • Wirth, Gregory;
    • Hadaschik, Boris;
    • Lucca, Ilaria;
    • John, Hubert;
    • Sauer, Andreas;
    • Müntener, Michael;
    • Bubendorf, Lukas;
    • Schneider, Martina;
    • Musilova, Jana;
    • Petrausch, Ulf
    Publication type:
    Article